Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

753 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 753 results

Testing effectiveness (Phase 2)Study completedNCT01265433
What this trial is testing

Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy

Who this might be right for
Malignant Pleural Mesothelioma
Sellas Life Sciences Group 41
Post-approval studies (Phase 4)Study completedNCT01174849
What this trial is testing

Pneumococcal Vaccines Early and in Combination

Who this might be right for
Otitis Media
Menzies School of Health Research 425
Testing effectiveness (Phase 2)UnknownNCT01898663
What this trial is testing

DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML

Who this might be right for
High-risk Soft Tissue Sarcoma
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)UnknownNCT02688686
What this trial is testing

Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases

Who this might be right for
Non-Small-Cell Lung Cancer With Bone Metastases
Affiliated Hospital to Academy of Military Medical Sciences 30
Large-scale testing (Phase 3)Study completedNCT00094653
What this trial is testing

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

Who this might be right for
MelanomaMetastases
Bristol-Myers Squibb 1,783
Early research (Phase 1)Study completedNCT02316457
What this trial is testing

RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID

Who this might be right for
Breast Cancer (Triple Negative Breast Cancer (TNBC))
BioNTech SE 42
Early research (Phase 1)Study completedNCT03718130
What this trial is testing

Combination HTNV and PUUV DNA Vaccine

Who this might be right for
Hantaan Virus Disease, Puumala Virus
U.S. Army Medical Research and Development Command 61
Testing effectiveness (Phase 2)Study completedNCT04491955
What this trial is testing

Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers

Who this might be right for
Small Bowel CancersColorectal Cancers
National Cancer Institute (NCI) 32
Very early researchLooking for participantsNCT06980155
What this trial is testing

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine 60
Early research (Phase 1)Active Not RecruitingNCT02432963
What this trial is testing

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

Who this might be right for
Adult Solid NeoplasmBladder CarcinomaColon Carcinoma+14 more
City of Hope Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT04260126
What this trial is testing

Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

Who this might be right for
Metastatic Head and Neck CancerRecurrent Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
PDS Biotechnology Corp. 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT05309421
What this trial is testing

A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma Stage IVUnresectable Melanoma
Evaxion Biotech A/S 17
Post-approval studies (Phase 4)WithdrawnNCT02135666
What this trial is testing

Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)

Who this might be right for
Hepatitis BHepatitis A
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT03953235
What this trial is testing

A Personalized Cancer Vaccine Targeting Shared Neoantigens

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerPancreatic Cancer+2 more
Gritstone bio, Inc. 39
Testing effectiveness (Phase 2)Study completedNCT00006385
What this trial is testing

Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00960115
What this trial is testing

Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Merck KGaA, Darmstadt, Germany 178
Testing effectiveness (Phase 2)Ended earlyNCT04187404
What this trial is testing

A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
Adrenocortical CarcinomaPheochromocytomaParaganglioma
Enterome 70
Large-scale testing (Phase 3)Study completedNCT01896739
What this trial is testing

A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants

Who this might be right for
Healthy Infants
LG Life Sciences 289
Early research (Phase 1)Study completedNCT00559975
What this trial is testing

Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine

Who this might be right for
Influenza Infection
Novartis 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06549257
What this trial is testing

Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 56
Next Page